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ABSTRACT African swine fever virus (ASFV) causes a lethal hemorrhagic disease of
domestic pigs, against which no vaccine is available. ASFV has a large, double-
stranded DNA genome that encodes over 150 proteins. Replication takes place predomi-
nantly in the cytoplasm of the cell and involves complex interactions with host cellular
components, including small noncoding RNAs (sncRNAs). A number of DNA viruses are
known to manipulate sncRNA either by encoding their own or disrupting host sncRNA.
To investigate the interplay between ASFV and sncRNAs, a study of host and viral small
RNAs extracted from ASFV-infected primary porcine macrophages (PAMs) was under-
taken. We discovered that ASFV infection had only a modest effect on host miRNAs,
with only 6 miRNAs differentially expressed during infection. The data also revealed 3
potential novel small RNAs encoded by ASFV, ASFVsRNA1-3. Further investigation of AS-
FVsRNA2 detected it in lymphoid tissue from pigs with ASF. Overexpression of ASFVs-
RNA2 led to an up to 1-log reduction in ASFV growth, indicating that ASFV utilizes a
virus-encoded small RNA to disrupt its own replication.
IMPORTANCE African swine fever (ASF) poses a major threat to pig populations and
food security worldwide. The disease is endemic to Africa and Eastern Europe and is
rapidly emerging into Asia, where it has led to the deaths of millions of pigs in the
last 12 months. The development of safe and effective vaccines to protect pigs
against ASF has been hindered by lack of understanding of the complex interactions
between ASFV and the host cell. We focused our work on characterizing the interac-
tions between ASFV and sncRNAs. Although comparatively modest changes to host
sncRNA abundances were observed upon ASFV infection, we discovered and charac-
terized a novel functional ASFV-encoded sncRNA. The results from this study add
important insights into ASFV host-pathogen interactions. This knowledge may be ex-
ploited to develop more effective ASFV vaccines that take advantage of the sncRNA
system.
KEYWORDS African swine fever virus, porcine, small RNA
African swine fever (ASF) is a highly pathogenic viral disease of swine. Virulentstrains cause acute hemorrhagic fever in domestic pigs, with mortality rates of up
to 100% (1). There is currently no effective vaccine or treatment (2). ASF is caused by
African swine fever virus (ASFV), the only member of the Asfarviridae family. The virus
sits within the nucleocytoplasmic large DNA virus (NCLDV) superfamily, which also
includes the Poxviridae. NCLDVs have large, double-stranded DNA genomes and rep-
licate predominantly in the cytoplasm of infected cells (3). ASFV replicates in cells of the
monocyte/macrophage lineage. This predominantly occurs in the cytoplasm of infected
cells, although an early stage of DNA replication has been identified in the nucleus (4).
ASFV evades the antiviral defenses in these cells by modulation of a number of host cell
pathways, including type I IFN induction (5), apoptosis (6), host-cell protein synthesis
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(7), and the NF-B and NFAT signaling pathways (8). Descriptions of these host-cell
interactions are reviewed in detail in reference 9. The nuclear phase of replication has
been shown to activate the host nuclear DNA damage response (DDR) (10) and also
leads to alteration of nuclear architecture by the disruption of subnuclear domains and
chromatin texture (11).
Small noncoding RNAs (sncRNAs) are classes of small RNA (200 nucleotides [nt])
that are involved in the regulation of gene expression and genome stability, predom-
inantly through RNA interference (RNAi) mechanisms. Eukaryotic cells produce multiple
classes of sncRNA, including microRNAs (miRNAs), PIWI-interacting RNAs (piRNAs), and
endogenous small interfering RNAs (siRNAs) (12). These sncRNAs are involved in many
biological processes, including apoptosis, differentiation, stress response, and immune
activation (13). Therefore, it is unsurprising that viruses manipulate and exploit sncRNAs
for their own benefit. Virus-encoded miRNAs have been identified in a number of DNA
virus families, including Herpesviridae, Polyomaviridae, Iridoviridae, Ascoviridae, Baculo-
viridae, and the Adenoviridae (14). These miRNAs play a variety of roles, including cell
proliferation regulation, control of apoptosis, and modulation of host immunity (15).
For example, the Kaposi’s sarcoma-associated herpesvirus (KSHV)-encoded miRNA,
miR-K1, regulates the switch between lytic and latent viral replication by control of
NF-B expression via targeting of the host IB transcript (16). Other classes of viral
ncRNAs have also been identified (reviewed in reference 17). An interesting example is
the herpes simplex virus 1 (HSV-1)-encoded non-miRNA small RNAs (LAT sRNA1 and
sRNA1) that regulate productive infection and inhibit apoptosis (18).
DNA viruses have also been shown to manipulate host sncRNAs by targeting specific
host miRNAs, as in the case of murine cytomegalovirus (MCMV) infection. MCMV
induces degradation of cellular miR-27a and miR-27b, which are important for MCMV
replication in vivo (19). A more nonspecific and global effect is wrought by vaccinia
virus (VACV), the prototypic poxvirus and NCLDV member, which induces widespread
disruption of host miRNAs by a process of 3= polyadenylation and decay (20, 21). As
RNAi is the major antiviral pathway in invertebrates, a number of arthropod-borne
(arboviruses) are known to manipulate sncRNA during replication to evade this immune
response. Interestingly, ASFV is currently the only known DNA arbovirus, and it repli-
cates in the soft tick vector of the Ornithodoros spp., which have a functional RNAi
system (22). Overall, it is apparent that manipulation of sncRNA systems is a common
feature of viruses to further their survival, replication, and pathogenesis.
In addition, the engineering of miRNA targeting has been developed as a novel
method to attenuate viral replication. This method involves the engineering of a virus
with host miRNA target sites in viral RNA, which is then subjected to miRNA silencing
(23). Originally, this methodology was limited to the attenuation of RNA viruses,
including poliovirus (24), Dengue virus (25), and human norovirus (26), with the miRNA
target sites added directly to the viral RNA genome. However, it has also been shown
to be an effective method of attenuating DNA virus replication, including VACV (27) and
human cytomegalovirus (27), by the targeting of specific transcripts. There is no
commercially available vaccine against ASFV, and current live-attenuated vaccine (LAV)
development relies on the deletion of viral genes associated with virulence and/or
immune evasion. There has been some success with these methods (28, 29), but as only
nonessential genes can be deleted, a challenge remains in selecting genes to get the
correct balance between attenuation and virulence. Therefore, miRNA targeting could
provide a novel method of attenuation that can be used in parallel with gene deletion.
However, the use of host miRNAs to target the virus would require that host miRNAs
are not disrupted during infection. Therefore, we sought to investigate the interaction
between ASFV and sncRNAs with the aim of gaining important insights into host-
pathogen interactions, knowledge of which could be used to optimize LAV ASFV
vaccines.
The effect of ASFV infection on host miRNAs has been investigated in vivo by
comparing miRNA expression in pigs infected with a virulent strain to those infected
with an attenuated strain (30). These authors identified 12 miRNAs that were differen-
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tially expressed. In addition, a further study looked in vivo at the potential for ASFV to
encode its own miRNAs and concluded that ASFV does not express miRNAs in vivo (31).
In our study, we investigated the effect of ASFV infection on sncRNA in primary porcine
alveolar macrophages in vitro. We found that virulent ASFV infection of primary porcine
macrophages had only a small impact on host miRNAs, with only 6 out of 178 identified
porcine miRNAs differentially expressed over a 16-h time period. Interestingly, we
discovered an ASFV-encoded sncRNA that, when overexpressed, led to a significant
reduction in ASFV replication.
(This article was submitted to an online preprint archive [32].)
RESULTS
ASFV infection does not induce polyadenylation or decay of cellular miRNAs.
VACV, the prototypic poxvirus and NCLDV member, has been shown to induce wide-
spread disruption of cellular miRNAs via a process of 3= polyadenylation and decay (20,
21). To investigate if ASFV shares the ability of VACV to induce miRNA polyadenylation
and decay, porcine alveolar macrophages (PAMs) were infected with the pathogenic
ASFV Benin 97/1 strain and Vero cells were infected with the Vero cell-adapted ASFV
strain, Ba71v. In parallel, PAMs and Vero cells were infected with VACV WR, with the
samples collected and processed for Northern blotting as described. The miRNA
miR-27b-3p was selected as a probe for this experiment, since it is extensively poly-
adenylated and degraded in VACV-infected cells (21). As expected, in VACV-infected
Vero cells at 0 h postinfection (hpi), mature miR-27b-3p was seen as a lower band (Fig.
1a, arrow), but by 6 hpi this mature form was almost undetectable, and there was a
higher-molecular-weight smear present in the lane, consistent with polyadenylation of
FIG 1 Infection with ASFV does not induce miRNA polyadenylation or decay. (a) Northern blot of RNA
extracted from Vero cells and porcine alveolar macrophages (PAMs) that were infected with either ASFV
or VACV. The blot was probed for miR-27b-3p and 5s and imaged on a Phosphorimager. Arrow, mature
miRNA; asterisk, polyadenylated miRNA. (b) Phosphorimager quantification of miR-27b-3p expression
normalized to 5S rRNA. The image and quantification is a representation of two biological repeats.
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the miRNA (Fig. 1a, asterisk). The higher-molecular-weight band above the smear in all
lanes represents the precursor miRNA. By 16 hpi there was nearly complete decay of all
forms of miR-27b-3p. In comparison, mature miR-27b-3p was present at all time points
in ASFV-infected Vero cells, with no evidence of polyadenylation or decay. In VACV-
infected PAMs, there was visible polyadenylation of miR-27b-3p but an absence of
decay. This is likely explained by VACV being unable to undergo a complete replication
cycle in PAMs (data not shown). There was no modification or reduction detected in the
amount of miR-27b-3p in ASFV-infected PAMs. Levels of miR-27b-3p expression were
quantified and normalized to 5S rRNA levels (Fig. 1b). This highlighted the approxi-
mately 100-fold reduction in miR-27b-3p expression in VACV-infected Vero cells,
whereas in ASFV-infected Vero cells and PAMs, no reduction was detected.
To look comprehensively at the effect of ASFV infection on sncRNA, we utilized small
RNA sequencing. RNA was extracted and sequenced from three biological repeats of
either mock- or ASFV-infected PAMs at 0, 6, and 16 hpi. Sequences aligning to 247
different mature Sus scrofa (obtained from miRbase [33]) miRNAs were obtained. Raw
data were subsequently filtered to remove miRNAs with an average of fewer than 5
reads per sample; this reduced the total number of miRNAs identified to 178. These
accounted for, on average, 73% of total trimmed small RNA reads. Data from a previous
study investigating the effect of VACV infection on host miRNAs was used as a
comparison (21). In ASFV-infected cells, there was no variation in the miRNA proportion
of the total small RNA reads at both early and late time points compared to uninfected
cells (Fig. 2a). This was in contrast to VACV-infected cells, which had a 30% reduction
in miRNA reads at an early time point (6 hpi) and over 50% reduction at late times (24
hpi) (Fig. 2b) (21). To assess the extent of ASFV-induced 3= modification of miRNAs, all
trimmed sequences were analyzed for nontemplated nucleotide 3= additions after
nucleotide position 19. No difference was detected between mock- and ASFV-infected
samples at both 6 and 16 hpi, with the proportion of reads containing miRNAs with 3=
mismatches remaining at approximately 17% (Fig. 2c). VACV infection led to a signifi-
cant increase in the proportion of 3= modified miRNA reads, which increased from 10%
in mock to 25% in infected samples at 6 hpi (Fig. 2d) (21). At 24 hpi, the difference was
less substantial and increased from 10% in mock to 15% in infected samples, although
it was still statistically significant (Fig. 2d). In a final analysis of 3= miRNA modification
during ASFV infection, the extent of 3= polyadenylation was examined by calculation of
the proportion of miRNA reads that contained 3 or more nontemplated 3= adenosine
residues beyond nucleotide position 19. No difference was detected between mock
and ASFV infected samples at either 6 or 16 hpi (Fig. 2e). The results from Northern
blotting and small RNA sequencing revealed that ASFV does not share the ability of
poxviruses to induce cellular miRNA polyadenylation and decay.
ASFV infection induces rapid changes in abundance of a select number of
miRNAs. To determine if ASFV infection induces differential abundance of specific
miRNAs, we used the small RNA sequencing data to analyze changes in the expression
of individual miRNAs during infection relative to mock-infected cells. The filtered data
(miRNA, 5 reads; 178 miRNAs in total) were used for this analysis. miRNAs were
analyzed for differential expression at 0, 6, and 16 hpi, relative to mock-treated samples,
and displayed on volcano plots (Fig. 3a to c) for each time point. The majority of cellular
miRNAs were not differentially expressed in response to ASFV infection. At both 6 and
16 hpi, only one miRNA was significantly differentially expressed (Fig. 3b and c).
Expression of miR-10b increased 3.89 log2 fold at 6 hpi, and miR-27b-5p expression
decreased 4.29 log2 fold at 16 hpi. Interestingly, the time point with the most changes
in miRNA expression was 0 h (Fig. 3a). The 0-h samples were collected after the virus
had been incubated on the cells for 1 h at 37°C. Four miRNAs were significantly
upregulated at this early time point: miR-10b, miR-486-1, miR-144, and miR-199a.
Overall, the sequencing data indicated that ASFV infection does not have a widespread
impact on host miRNA expression but does lead to rapid changes in the abundance of
a small number of miRNAs.
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To validate the miRNA expression changes identified from the sequencing analysis,
quantitative reverse transcription-PCR (RT-qPCR) was used to measure the abundance
of individual miRNAs. Three more biological repeats of ASFV infections were repeated
in PAMs (taken from 3 different pigs), RNA was extracted at 0, 6, and 16 hpi, and miRNA
expression was examined by RT-qPCR. To confirm that the miRNA expression changes
were not the result of unspecific stimulation of macrophages due to cell debris in the
virus preparation, we also tested miRNA expression, by RT-qPCR, after the addition of
a mock virus preparation (defined as a lysate of primary porcine bone marrow cells
FIG 2 ASFV does not induce widespread polyadenylation or decay of cellular miRNAs. (a and b) The proportion of sequencing reads that mapped
to known host miRNAs that were PAM infected or mock infected with ASFV (a) and in HeLa cells infected or mock infected with VACV at early
and late time points (b). (c and d) The proportion of 3= modified miRNA that contained at least 1 nontemplated nucleotide after position 19 as
a proportion of total sequencing reads, in ASFV mock-infected and infected PAMs (c) and VACV mock-infected and infected HeLa cells (d). (e)
Proportion of miRNA containing 3 or more 3= nontemplated adenosine residues after nucleotide position 19 in ASFV mock-infected and infected
PAMs. Data represent the means from three biological repeats, and error bars represent standard errors of the means (SEM). Data were statistically
analyzed using Student’s t test. ns, P 0.05; ***, P 0.001; ****, P 0.0001. Data from panels b and d were taken from supporting information
from reference 18 and represent means from three biological replicates.
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prepared exactly as an ASFV stock would be but without any virus added). In infected
PAMs, RT-qPCR validated the upregulation of miR-10b at 0 h to comparable levels
detected in the sequencing (Fig. 4a); however, the upregulation at 6 hpi was not
detected. Validation of miR-144 expression followed a pattern similar to that of
sequencing, although the upregulation was not as substantial (Fig. 4b), with a log2 fold
change of only 2.2 compared to 7.81 found by sequencing. RT-qPCR validation of
miR-27b-5p expression showed a trend for downregulation, but, again, this was not as
substantial as that detected by sequencing, with a log2 fold change of only 1,
compared to 4 for the sequencing data at 16 hpi (Fig. 4c). RT-qPCR was unable to
FIG 3 ASFV infection induces rapid changes in the abundance of a select number of miRNAs in PAMs. Volcano plots showing the differential
expression of host miRNAs in ASFV-infected cells relative to mock-infected cells at 0 hpi (a), 6 hpi (b), and 16 hpi (c). The miRNAs that were
differentially expressed with a significant adjusted P value (0.05) are detailed in the table below each volcano plot.
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FIG 4 Differential expression of miR-10b and miR-144 in ASFV Benin 97/1-infected PAMs but not ASFV Ba71v-infected Vero cells. (a to d)
Changes in expression of miR-10b (a), miR-144 (b), miR-27b-5p (c), or miR-486-1 (d) in PAMs infected with ASFV Benin 97/1 or after the
(Continued on next page)
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validate miR-486-1 upregulation (Fig. 4d). We were also unable to validate expression
of miR-199a-1 due to its low expression in PAMs. With an average of only 17 miR-199a-1
reads per sample, a standard curve could not be generated. The mock virus preparation
did not lead to the dysregulation of any of the tested miRNAs (Fig. 4a to d).
We also analyzed miRNA abundance in response to ASFV infection in Vero cells
using the Vero cell-adapted strain, Ba71v. The expression pattern of the tested miRNAs
did not match that of Benin 97/1-infected PAMs, with no substantial change in the
expression of any of the studied miRNAs (Fig. 4e and f), with the log2 fold change not
changing beyond 1, indicating that the changes detected in PAMs with Benin 97/1
were cell type specific or strain specific. Overall, we conclude that ASFV infection has a
focused impact on the abundance of cellular miRNAs. This impact is limited to the
upregulation of a small number of miRNAs (miR-10b and miR-144) at very early time
points during infection, specifically of Benin 97/1-infected PAMs.
Identification of three ASFV small noncoding RNAs. As ASFV does not mirror
poxviruses by disrupting the host miRNA system on a widespread scale, there remains
the potential for ASFV to utilize this system to encode its own miRNAs. To investigate
this possibility, we aligned small RNA reads that did not map to known Sus scrofa
sequences to the ASFV Benin 97/1 genome and the Ba71v genome, as this includes fully
sequenced genome termini that contain the difficult-to-sequence terminal inverted
repeats (TIRs). Plotting these aligned reads along the ASFV Benin 97/1 genome (Fig. 5a)
revealed a single peak of small RNA reads beginning at position 82625. This was also
detected when aligned to Ba71v, beginning at base pair (bp) 71302 (Fig. 5b). In
addition, the Ba71v alignment revealed two peaks of small RNA reads at bp 57 and bp
170022, indicating that these are located in the genome TIRs. We termed these 3 small
RNA sequences ASFV small RNA 1, 2, and 3 (ASFVsRNA1, ASFVsRNA2, and ASFVsRNA3).
Both ASFVsRNA1 and ASFvsRNA3 were only detectable at 16 hpi, with an average
(mean) of approximately 100 reads per sample. ASFVsRNA2 was detectable at both 6
and 16 hpi, with an average (mean) of 240 reads per sample. The sequences of the three
small RNAs are shown in Fig. 5c. Analysis of sequencing data from individual samples
revealed that these small RNAs were only detected in infected samples (Fig. 5d, e, and
f), supporting the hypothesis that the reads were virus derived. Due to the higher mean
abundance of ASFVsRNA2 and its appearance at 6 as well as 16 hpi, this RNA was taken
forward for further analysis.
Characterization of ASFV-encoded small RNA2. The sequence of ASFVsRNA2
aligns antisense (on the noncoding strand) to C147L (Fig. 6a), the RNA polymerase
subunit 6. This region of the gene is 100% conserved in all sequenced ASFV genomes
(Fig. 6b). Interestingly, ASFVsRNA2 had a variable number of 3= U residues. A large
proportion of reads did not contain any 3= uridines, 90% at 6 hpi, which decreased to
70% by 16 hpi (Fig. 6c). The number of reads containing 1 to 12 3= U residues increased
over time from 10% at 6 hpi to 30% by 16 hpi (Fig. 6c). The first 9 U residues are
templated in the viral genome (depicted in Fig. 6b), although around 10% of all reads
have 10 to 12 residues at 16 hpi.
The expression of the ASFVsRNA2 was validated using RT-qPCR. RNA from both
ASFV Benin 97/1-infected PAMs and Ba71v-infected Vero cells was extracted at 0, 6, and
16 hpi. RT-qPCR was performed using a primer specific for ASFVsRNA2 [without the
poly(U) sequence]. ASFVsRNA2 was detectable at very low levels at 0 hpi (Fig. 7a), with
40-Ct values 5 or below in both cell types. By 6 hpi, ASFVsRNA2 was readily detected,
with a mean 40-Ct value of at least 12 in both cell types, and was even more abundant
by 16 hpi, with the 40-Ct value increasing by at least 2. Northern blotting was also used
FIG 4 Legend (Continued)
addition of a mock virus preparation at 0, 6, and 16 hpi were measured by RT-qPCR. Fold changes from miRNA sequencing are provided for
comparison. (e to h) Changes in expression of miR-10b (e), miR-144 (f), miR-27b-5p (g), or miR-486-1 (h) in Vero cells infected with ASFV Ba71v
at 0, 6, and 16 hpi were measured by RT-qPCR. miRNA expression was normalized to U6 small RNA, and fold change was calculated by the
Pfaffl method. Data represent means from 3 biological repeats, and error bars indicate SEMs. Black bars, sequencing results; pink bars, Benin
97/1-infected PAM RT-qPCR results; teal bars, mock virus-treated PAM RT-qPCR results.
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to detect ASFVsRNA2. A radiolabeled DNA probe perfectly complementary to ASFVs-
RNA2 was used to perform Northern blotting on the same cellular RNA samples. The 5S
rRNA was used as a loading control. The probe detected a small RNA species in infected
PAMs at 6 hpi, increasing in intensity by 16 hpi. An RNA molecule of similar mobility was
detected in infected Vero samples at 16 hpi (Fig. 7b).
To assess ASFVsRNA2 expression in vivo, RNA was analyzed from tissues taken from
pigs experimentally infected with ASFV. Outbred pigs were challenged with ASFV
OURT88/1 and euthanized 5 days postchallenge due to exhibiting moderate clinical
signs consistent with ASF. At postmortem examination, the submandibular, mesenteric,
gastrohepatic, and renal lymph nodes, as well as the spleen, were taken from three
pigs. Samples of the same tissues were also taken from one uninfected animal. RNA was
extracted and RT-qPCR performed using the ASFVsRNA2-specific primer. ASFVsRNA2
was not detected in any of the samples taken from the uninfected animal. ASFVsRNA2
was detectable in all samples from animals infected with ASFV, with 40-Ct values
ranging from 8 to 12 (Fig. 7c), indicating that ASFVsRNA2 is produced during in vivo
infection.
ASFVsRNA2 does not function as an miRNA. To investigate whether ASFVsRNA2
is an miRNA, we investigated whether it is loaded into Argonaute 2 (Ago2), an essential
FIG 5 Mapping of unaligned small RNA reads to ASFV genome reveals peaks of small RNA sequences. (a) Plot showing small RNA sequencing reads mapping
to the ASFV Benin 97/1 genome. The position along the genome, in base pairs, is along the x axis, and the number of reads is on the y axis. (b) Plot of reads
mapping to the Ba71v ASFV genome (this sequence includes the inverted terminal repeats). (c) Table detailing the location and sequence of the peaks in reads.
The average (mean) number of reads per sample at each time point is shown for ASFVsRNA1 (d), ASFVsRNA2 (e), and ASFVsRNA3 (f). Error bars indicate SEM.
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protein involved in miRNA function. Lysates were harvested from ASFV-infected PAMs
and incubated with either an anti-Ago2 antibody or nonimmune rabbit serum as a
negative control. Antibody-protein-RNA complexes were immunoprecipitated (IP), and
Western blotting was performed to identify enrichment of Ago2 in the anti-Ago2
antibody complexes compared to the nonimmune antibody complexes and the non-
precipitated cell lysate (Fig. 8a). RNA then was extracted and RT-qPCR performed for
ASFVsRNA2 and the miRNA miR-21, a highly expressed miRNA known to be loaded in
RISC. Data were normalized to the small U6 RNA, which is not loaded in RISC. An 8-log2
fold enrichment of miR-21 was detected in the complexes precipitated with the
anti-AGO2 antibody, confirming the success of the IP (Fig. 8b). However, ASFVsRNA2
was very poorly enriched (log2 fold change of 1) after IP, indicating that ASFVsRNA2
does not function as an miRNA. We additionally used multiple RNA folding prediction
programs, including miRNAFold (34), RNAfold (35), and RNAstructure (36), to predict if
ASFVsRNA2 can form an miRNA stem-loop precursor. However, none of the in silico
hairpin structures produced were convincing as miRNA hairpin precursors (data not
shown), supporting the immunoprecipitation data, suggesting that ASFVsRNA2 does
not function as an miRNA.
Transfection of a mimic of ASFVsRNA2 reduces viral replication.We next sought
to investigate whether ASFVsRNA2 performs a function during ASFV replication. This
was achieved by synthesizing single-stranded RNA mimics of the ASFVsRNA2 with and
without the 3= poly(U) sequence. These RNA mimics were stabilized with 2=-fluoro
modifications, as other sncRNAs have been shown to be functional and have targeting
activity with this modification (37). The experiments were performed in Vero cells using
FIG 6 Alignment of ASFVsRNA2 to the ASFV genome. (a) Location of the ASFVsRNA2 sequence in the C147L coding region. Arrows represent
coding direction. (b) Alignment of this region in multiple strains of ASFV. The boxed region highlights the ASFVsRNA2 sequence (alignment
performed using Clustal Omega). Numbering is the genome position in ASFV Benin 97/1. (c) The proportion of reads and the number of 3= uridine
residues of ASFVsRNA2.
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Ba71v rather than PAMs due to the higher transfection efficiency of Vero cells. The
ability of Vero cells to be both transfected with an RNA mimic and infected with ASFV
was first examined. Cells were transfected with a Dy547-labeled miRNA mimic, known
as miRDIAN, and at 12 h later infected with ASFV Ba71v. (After a further 24 h, cells were
fixed, permeabilized, and labeled with an antibody targeted to ASFV early CP204L/p30
protein.) Analysis by confocal microscopy showed that all ASFV-infected cells (p30
FIG 7 ASFVsRNA2 is expressed in vivo. Expression of ASFVsRNA2 was determined in ASFV-infected
porcine macrophages and Vero cells at 0, 6, and 16 hpi by RT-qPCR (a) or Northern blotting (b). 5S rRNA
served as a loading control. (c) RT-qPCR analysis of ASFVsRNA2 expression in tissue samples from pigs
infected with ASFV OUR88/1. SMLN, submandibular lymph node; MELN, mesenteric lymph node; GHLN,
gastrohepatic lymph node; RLN, renal lymph node. In panels a and c, data represent means from 3
biological replicates and error bars indicate SEMs.
FIG 8 ASFVsRNA2 is not produced through an Ago2-dependent pathway. (a) Western blot of ASFV-
infected PAM lysates before and after Ago2 immunoprecipitation using anti-Ago2 and anti-actin anti-
bodies. Pre-IP, lysate before immunoprecipitation; ago2-IP, Ago2 immunoprecipitation lysate. Rabbit-IP,
preimmune rabbit serum control immunoprecipitation. (b) The log2 fold enrichment after RT-qPCR for
miR-21 and ASFVsRNA2 in the Ago2 immunoprecipitation. Expression was normalized to U6 small RNA
and fold change calculated by the Pfaffl method. Data represent means from 3 technical replicates, and
error bars indicate SEM.
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positive) were also transfected with the miRNA mimic, visible as red dots on the images
(Fig. 9a), indicating transfection and infection of the same cells had occurred.
A single-step ASFV growth curve was then carried out on Vero cells transfected with
either the ASFVsRNA2 mimic, ASFVsRNA2 poly(U) mimic, or a negative-control mimic or
were left untransfected. After 12 h, cells were infected with ASFV Ba71v, and the
amount of virus present was determined at the time points shown by calculating the
50% tissue culture infective dose (TCID50) (Fig. 9b). The negative-control mimic had no
effect on viral replication, with no difference in viral TCID50 at any time point compared
to the nontransfected cells. At 12 hpi, ASFV replication in cells transfected with the
ASFVsRNA2 mimic had an approximately 0.5-log reduction compared to the nontrans-
fected cells. Replication in these cells recovered by 24 hpi to a level similar to that of
the negative-control and nontransfected cells. Interestingly, the ASFVsRNA2 poly(U)
mimic had a significant impact on replication only at 24 hpi, with an approximately
1-log reduction. Therefore, the results suggest that ASFV utilizes both the 3= uridylated
and nonuridylated forms of this virus-encoded small RNA to regulate its own replica-
tion, and that the two forms are involved at different time points during replication.
As ASFVsRNA2 lies antisense to the RNA polymerase subunit 6 gene, C147L, it is
possible that it functions by targeting the C147L mRNA transcript (self-targeting). To
investigate this, RNA was extracted from samples collected in parallel to the growth
curve experiment (Fig. 9b) at 12 and 24 hpi. RT-qPCR analysis was performed for C147L
and another ASFV gene, p72. Expression was normalized to 18s rRNA and fold change
was calculated relative to infected cells that had been mock transfected. At 12 hpi,
C147L mRNA abundance was not affected by the transfection of either the ncRNA
mimic or the ncRNA poly(U) mimic (Fig. 9c). Transfection of the negative-control
(nontargeting) mimic had a modest, approximately 1.5-log2 fold changed downregu-
lation of C147L expression compared to the mock-transfected cells. At 24 hpi, trans-
fection of all mimics, including the nontargeting control, led to an upregulation of
between a 3- and 4-log2 fold change of C147L compared to the mock-transfected cells
(Fig. 9d). In summary, no change to the C147L mRNA levels was induced by either the
ncRNA mimic or the ncRNA poly(U) mimic at 12 or 24 hpi. To assess if the ncRNAs
affected the expression of other ASFV genes, expression of the ASFV p72 gene was also
analyzed. At 12 hpi, expression of p72 gave a pattern similar to that of C147L, with
relatively little impact of ASFVsRNA2 mimic transfection, and the negative-control
mimic having the largest effect, causing a 2-log2 fold change in downregulation relative
to mock-transfected cells (Fig. 9e). At 24 hpi, there was very little difference in p72
mRNA abundance in response to transfection with any of the three mimics (Fig. 9f).
Overall, this experiment indicated that transfection of ASFVsRNA2 mimics does not lead
to a specific downregulation of C147L mRNA during ASFV replication or a global
reduction in ASFV transcription.
DISCUSSION
With no effective vaccine or treatment, methods to control ASFV outbreaks are
limited. After reaching the European Union (EU) in 2014, ASFV has subsequently spread
throughout Eastern Europe. The virus emerged in China in 2018 and has since spread
rapidly across Southeast Asia, with outbreaks declared in countries including Vietnam,
Cambodia, Mongolia, the Philippines, and Indonesia (38). ASFV in Southeast Asia,
particularly China, which is the world’s largest pig producer, has substantially reduced
food security in the region (39). Therefore, improving current ASFV vaccines and
developing novel vaccines is a priority.
We sought to investigate the interaction between ASFV and sncRNAs to gain more
knowledge of ASFV host-pathogen interactions. Many viruses have been found to
exploit and manipulate sncRNAs. This can range from subtle effects on specific host
miRNAs to widespread disruption of miRNAs, such as in the case of poxviruses (20, 21).
The mechanism of VACV-mediated miRNA polyadenylation is assumed to be mediated
by the virus-encoded poly(A) polymerase (PAP), VP55 (20). The viral PAP is conserved
throughout the NCLDV superfamily, with the C475L gene identified as the putative
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FIG 9 Expression of a mimic of ASFVsRNA2 leads to a reduction in ASFV replication. (a) Vero cells transfected with
miRIDIAN mimic transfection control with Dy547 for 24 h were subsequently infected with ASFV Ba71v (MOI, 5).
After 24 h, cells were fixed and labeled to confirm cells can be successfully transfected and infected. (b) Vero cells
were transfected with RNA mimics of ASFVsRNA2, with and without poly(U) sequence. After 24 h, cells were
infected with ASFV Ba71v (MOI, 5), and supernatants were taken at 0, 4, 8, 12, and 24 hpi and titrated on Vero
cells. TCID50 was calculated by the Spearman-Karber method. Error bars indicate SEM. *, P 0.0111; ***,
P 0.001; determined by repeated-measures two-way ANOVA. Results are representative of two biological
repeats. (c to f) RT-qPCR analysis of C147L expression during the growth curve at 12 hpi (c) and 24 hpi (d) and
ASFV p72 expression at 12 hpi (e) and 24 hpi (f). Expression is shown relative to mock transfection (set to 0). Data
represent means from 3 technical replicates. Error bars indicate SEM.
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ASFV PAP (40). Therefore, we first investigated whether ASFV shares the ability of
poxviruses to induce miRNA polyadenylation and their subsequent decay. Both North-
ern blotting and small RNA sequencing revealed no evidence of widespread miRNA
polyadenylation and decay in ASFV-infected cells. Therefore, this characteristic is not
conserved throughout the NCLDV superfamily and may be unique to poxviruses.
In contrast to poxviruses, this study found ASFV infection has only a modest impact
on host miRNAs, with only 6 miRNAs identified by sequencing to be differentially
expressed during ASFV infection, and only 3 of these robustly validated by RT-qPCR.
This more subtle effect on miRNAs is more common in virus infections than the
widespread disruption that poxviruses induce (41). For example, pseudorabies virus-
infected porcine dendritic cells led to the differential expression of only 8 miRNAs (42).
A previous study examined miRNA expression in spleen and lymph node collected from
pigs inoculated with a virulent and attenuated ASFV strain (19). This study identified
differential regulation of 22 miRNAs in the spleen and 33 in the lymph node 3 days
postinoculation. The only miRNA identified common to this study was miR-10b, which
was found to be lightly downregulated between 3 and 7 dpi for animals infected with
a virulent ASFV strain. It is difficult to directly compare results, as the previous study
compared miRNA expression in pigs infected with a virulent strain to those infected
with an attenuated strain, not uninfected animals. Additionally, our in vitro study
focused on a single viral replication cycle over 16 h, whereas the in vivo experiment
analyzed viral infection over multiple days. However, the identification of miR-10b as
differentially expressed in vivo supports our theory that miR-10b plays a role during
ASFV infection.
The upregulation of miR-10b occurred at 0 hpi, after the virus has been incubated
on cells for only 1 h, but then rapidly decreased in abundance by 6 hpi. Further
experiments using the porcine pestivirus classical swine fever virus (CSFV) also led to a
similar pattern in miR-10b expression, with rapid upregulation during the first hour of
infection and subsequent decrease (data not shown). Both ASFV and CSFV are envel-
oped viruses and have been found to enter porcine macrophages via endocytosis (43,
44). In macrophages, miR-10b is known to target ATP binding cassette transporter A1
ABCA1 (45), which is involved in the regulation of cholesterol efflux. During infection
with ASFV, cholesterol remodeling is essential in the establishment of productive viral
infection, and disruption of cellular cholesterol efflux leads to the impairment of virus
entry and viral particles remained trapped in endosomes (46). This suggests a link
between miR-10b, ABCA1, and cholesterol efflux during endocyte-mediated entry of
ASFV in macrophages.
Infection of Vero cells with Ba71v did not induce the same response as infection of
PAMs with Benin 97/1, indicating that the changes were either cell type specific or
strain specific. This could be linked to differences in the IFN response. Vero cells are
defective at producing type I IFN (47), which is the major antiviral response in mammals
and, therefore, could explain the variation in miRNA response between the cell types.
The difference between Vero cells and PAMs may also be a result of the different viral
strains used. Compared to Benin 97/1, the Vero cell-adapted Ba71v has an 8,250-bp
deletion in its genome that carries 6 copies of the MGF 360 genes and one copy of
MGF-505; there is also a 3-kbp deletion at the right end of the genome (48).
A key finding of this study was identification and characterization of an ASFV
sncRNA, ASFVsRNA2. Due to their large genome size, DNA viruses have the coding
capacity to encode miRNAs, and many do, predominantly the nuclear replicating
herpesviruses. As canonical miRNA biogenesis begins in the nucleus with host RNA Pol
II transcription from the viral genome, it is assumed viral miRNA biogenesis requires a
nuclear phase of viral replication. Indeed, virus-encoded miRNAs have been identified
in NCLDVs that also have a nuclear phase of replication. These are in two iridoviruses:
Singapore grouper iridovirus (SGIV) (49) and Tiger Frog Virus (TGV) (50). Several studies
have identified the presence of ASFV genomes in the nucleus at early time points in
infection (51); this nuclear phase remains poorly understood, but it indicates the
possibility that ASFV encodes miRNAs.
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Our study identified ASFVsRNA2 in both PAMs and tissues from pigs with ASFV (Fig.
7a to c). A previous in vivo study concluded that ASFV does not express viral miRNAs
in experimentally infected pigs (31). However, the previous study restricted its analysis
to miRNA only based on predictions of precursor miRNA structures and did not
consider other classes of sncRNA. Since a number of virus families encode different
classes of sncRNAs (reviewed in reference 17), we chose to sequence the small RNA
fraction from ASFV-infected cells without bias, which allowed us to report the first
identification of three ASFV-encoded sncRNAs. Due to a higher mean abundance and
earlier detection (6 hpi), only one of these sRNAs, ASFVsRNA2, was taken forward for
further characterization. ASFVsRNA2 is conserved in all sequenced isolates (Fig. 6b).
However, as ASFVsRNA1 and -3 are located in the genome termini, it is unknown if
these are conserved in other ASFV isolates, as the genotype I isolates Ba71v and
47/Ss/2008 remain the only isolates to have fully sequenced genome termini due to the
difficulty in sequencing the TIRs. This supported our decision to focus on ASFVsRNA2.
Our research has indicated that ASFVsRNA2 does not fit the classic miRNA biogen-
esis pathway, as it does not have an identifiable hairpin precursor and fails to enrich in
an Ago2 immunoprecipitate. Ago2 immunoprecipitation is a difficult technique to carry
out, and it remains possible that our finding represents a false negative. However, it is
known that a number of viral miRNAs are produced through noncanonical pathways.
(52), for example, miRNAs encoded by murine gammaherpesvirus 68 (MHV68), in which
the precursor miRNAs are located in a tRNA-like structure (53). Despite this variety of
biogenesis pathways, miRNAs are required to be loaded into an Ago protein in order
to function. Pigs, like other mammals, have been found to encode 4 Ago proteins
(Ago1-4) (54), although only Ago2 is catalytically active and has the ability to cleave
target mRNA (55). It has been reported that miRNAs are not sorted into distinct human
Ago proteins (56), so miRNAs would be expected to be found in all Ago proteins.
Therefore, our inability to detect ASFVsRNA2 enrichment in an Ago2 immunoprecipi-
tation indicates that ASFVsRNA2 does not behave like a classical miRNA molecule.
The presence of polyuridine [poly(U)] residues on the 3= end of ASFVsRNA2 is
intriguing. The first 9 of these uridine residues are templated in the ASFV genome,
although a small percentage of reads at 16 hpi have 10 to 12 uridine residues. Some of
the U residues detected may, therefore, be templated, and some could arise from
template slippage. It is likely that the variation in the number of templated uridine
residues is a result of ASFVsRNA2 biogenesis. ASFV transcription termination takes
place at a conserved motif of seven or more consecutive thymidylate residues (57), and
this poly(T) motif is retained in the mRNA (58), so it is possible this poly(U) motif is the
termination signal for ASFVsRNA2 transcription. Recent detailed viral transcriptome
analysis of ASFV has indicated that this motif is the termination sequence for the gene
upstream of C475L, C135R (59). Therefore, it is possible ASFVsRNA2 is generated
through modification of the C135R mRNA transcript or as a result of readthrough
transcription of this transcript. In VACV, readthrough transcription is common due to
the imprecise control of transcription termination of intermediate and late genes (60).
ASFV exerts stricter control over transcription termination than VACV, with termination
of all gene classes occurring at a poly(T) motif, and readthrough transcription does not
appear to be a common feature. In support of this, scrutiny of transcriptome sequenc-
ing (RNA-seq) reads from ASFV replication transcriptome analysis revealed little evi-
dence of readthrough transcription (61). Readthrough transcription has been described
from the Y118L gene (62), and no RNA-seq reads from these genes were detected in our
study. Therefore, if ASFVsRNA2 was an artifact of readthrough transcription, it seems
unlikely that this would be the only sequencing read detected at this abundance.
The nontemplated additions indicate a modification to ASFVsRNA2, as the main
function of noncoding RNA uridylation is to promote its degradation (63). However, it
can also have a number of other functions. For example, uridylation of the miRNA let-7
precursor is required for let-7 biogenesis (64). It can also control the activity of
noncoding RNA, for instance, uridylation of miR-26 prevents it from binding to its target
interleukin-6 transcript but does not affect miRNA stability (65). The functional signif-
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icance of the uridine residues, templated or not, on the 3= end of ASFvsRNA2 is
currently unknown, although our work has indicated it is of importance.
Overexpression of ASFVsRNA2 reduced ASFV replication in Vero cells, suggesting it
has a role in the control of viral replication. This relatively modest effect, between 0.5-
and 1-log reduction, is consistent with sncRNA gene targeting, since miRNAs usually
regulate gene transcript levels by less than 2-fold (66). Even though we do not believe
ASFVsRNA2 to be an miRNA, the predominant function of all classes of sncRNAs is to
induce gene silencing (67). Therefore, we would also expect ASFVsRNA2 to have only
a modest effect. Many viruses are known to encode activators and repressors to finely
control their life cycle in order to replicate in the face of the host immune response. An
interesting example of this is the human cytomegalovirus (HCMV) miRNA miR-UL112-1,
which has been found to downregulate multiple viral genes involved in replication,
leading to a decrease in genomic viral DNA (68). There is no suitable porcine cell line
in which to confirm the reduction in replication seen in Vero cells.
As ASFVsRNA2 has perfect complementarity to ASFV C147L, the region where it is
derived, we investigated whether this small RNA was self-targeting. Self-targeting is
already known to occur for virus-encoded miRNAs. For example, the EBV-encoded
miRNA, miR-BART-2, is encoded antisense to its target, the viral DNA polymerase BALF5
(69). It is hypothesized that this allows EBV to regulate its transition from latent to lytic
infection. ASFV does not have a latent stage of infection but does have strict temporal
control of gene expression. Therefore, it is possible that ASFV uses ASFVsRNA2 to exert
subtle control over C147L expression, an RNA polymerase subunit, to aid its strict
control over gene expression. However, RT-qPCR analysis did not find any significant
effect of ASFVsRNA2 mimic transfection on C147L expression during a growth curve.
Therefore, it appears that ASFVsRNA2 does not function by disrupting the stability of
the C147L transcript.
In summary, we have found that ASFV infection has a very modest impact on host
sncRNA and instead utilizes this system to encode its own, ASFVsRNA2, which retards
viral replication. The discovery of an ASFV-encoded sncRNA has added another level to
the knowledge of ASFV replication. Furthermore, the finding that ASFV induces little
disruption to the host miRNA system opens up the possibility of utilizing host miRNAs
to target and downregulate ASFV genes, potentially aiding the development of the
next generation of ASFV vaccines.
MATERIALS AND METHODS
Cells and viruses. African green monkey epithelial cells (Vero) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) (Life Technologies) containing 100 U/ml penicillin, 100 g/ml streptomycin
(Sigma), and 10% fetal bovine serum (FBS) (Life Technologies). Cells were maintained at 37°C with 5%
CO2 and were passaged regularly to maintain viability. Primary porcine cells were derived from 4-week-
old Large White outbred pigs. Porcine alveolar macrophages (PAMs) were obtained by lung lavage with
phosphate-buffered saline (PBS) and maintained in RPMI 1640 GlutaMAX (Life Technologies) containing
100 U/ml penicillin, 100 g/ml streptomycin (Sigma), and 10% porcine serum (BioSera). Bone marrow
cells were prepared from femur bones and maintained in Earle’s balanced salt solution (EBSS) with 100
U/ml penicillin, 100 g/ml streptomycin (Sigma), 10% porcine serum (BioSera), and 10 mM HEPES. The
pathogenic ASFV Benin 97/1, previously described in reference 48, was grown in primary porcine bone
marrow cells and the tissue culture-adapted ASFV BA71V, previously described in reference 70, was
grown in Vero cells. The mock virus preparation used in Fig. 4 was prepared in parallel with a pathogenic
ASFV Benin 97/1 virus stock on primary porcine bone marrow cells, but no virus was added to the cells.
Experiments involving VACV used the Western Reserve (VACV-WR) strain, prepared by purification on
36% (wt/vol) sucrose cushion. Experiments involving CSFV used the Brescia strain, kindly provided by
Julian Seago (The Pirbright Institute).
Animal experiments and ethics statement. Animal experiments were carried out under the Home
Office Animals (Scientific Procedures) Act (1986) (ASPA) and were approved by the Animal Welfare and
Ethical Review Board (AWERB) of The Pirbright Institute. The animals were housed in accordance with the
Code of Practice for the Housing and Care of Animals Bred, Supplied or Used for Scientific Purposes, and
bedding and species-specific enrichment were provided throughout the study to ensure high standards
of welfare. Through careful monitoring, pigs that reached the scientific or humane endpoints of the
studies were euthanized by an overdose of anesthetic. All procedures were conducted by Personal
License holders who were trained and competent and under the auspices of Project Licences. Female
Landrace  Large White (Yorkshire)  Hampshire pigs were obtained from a high-health farm in the
United Kingdom. Animals were challenged intramuscularly in the rump with 10,000 hemabsorbing units
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of the OUR T88/1 strain of ASFV. Tissue samples were collected from three pigs at postmortem, 5 days
postchallenge.
Preparation of RNA samples. Confluent 6-well plates of Vero cells and PAMs were mock infected or
infected with ASFV or VACV at a multiplicity of infection (MOI) of 10 for 1 h at 37°C. The inoculum was
removed (0-h time point), cells were washed 3 in PBS, and medium, containing 2.5% serum, was
replaced. At 0, 6, and 16 hpi, cells were harvested into an appropriate volume of QIAzol lysis reagent
(Qiagen) and RNA prepared using the miRNeasy minikit (Qiagen). For RNA extraction from animal tissues,
the tissues were harvested into RNAlater (Life Technologies) and stored at 80°C. Fifty milligrams of
tissue was added to 700 l Qiazol lysis reagent (Qiagen) and homogenized using tissue grinding lysate
matrix beads (MP Biomedicals). RNA was prepared using the miRNeasy minikit (Qiagen), including an
on-column DNase digest (Qiagen).
Northern blot analysis. Northern blotting was carried as described in reference 21. Briefly, 5 g RNA
was mixed with 2 Tris-borate-EDTA (TBE)-UREA buffer (Novex) and heated at 70°C for 3 min. Samples
were run on a 15% polyacrylamide TBE-UREA gel (Bio-Rad). The gel was then transferred to a solution of
0.5 TBE containing 10,000 SYBR gold (Invitrogen) and visualized under UV light to check for equal
loading. The RNA was transferred to a Hybond N membrane (Amersham) using a semidry transfer
machine and cross-linked as described in reference 71. DNA probes perfectly complementary to
miR-27b-3p, ASFVsRNA2, and 5S rRNA were prepared by labeling with 32P using the mirVana probe and
marker kit (Ambion). Membranes were prehybridized in ULTRAhyb hybridization buffer (Ambion) for 1 h
at 42°C prior to incubation with a 32P-labeled DNA probe overnight at 42°C. Membranes were then
washed twice in 2 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate) with 0.1% SDS for 15 min
and laid against a phosphorimage screen for 4 to 6 h. Labeling was detected using a Typhoon FLA 7000
phosphorimager (GE Healthcare). To strip the membrane for reprobing, it was washed in a solution of
boiling 0.1% SDS for 30 min.
Small RNA sequencing. Integrity of the RNA was measured on a Bioanalyzer (Agilent), with all samples
having a RIN value of 8 or above. Small RNA sequencing libraries were prepared using the CleanTag small RNA
kit (TriLink). Libraries were pooled, gel purified on a 5% polyacrylamide TBE gel (Bio-Rad), and sequenced on
an Illumina HiSeq (Edinburgh Genomics). An average of 7,013,808  3,522,153 reads per sample was
generated. The quality of reads was assessed using FASTQC and adapters trimmed using cutadapt software.
Sequences were collapsed within each sample to generate a nonredundant set of fasta sequences.
Singletons were not included. The reference used for alignment was version 10.2 of the Sus scrofa
genome obtained from Ensembl; only full-length perfect match (FLPM) sequences were counted.
Sequences aligning to the genome were subsequently used as input for a mirDeep2 analysis. Alignments
were performed using a noncurrent version of bowtie-based Perl script (mapper.pl) that forms part of the
mirDeep2 software package. The mirDeep2 version was 2.0.0.4, and the bowtie version was 0.12.5.
Parameters used were -o 20 -l 17 -r 100 -c. The analysis used Sus scrofa mature (3p and 5p forms) and
precursor sequences obtained from mirBase (release 21). Small RNA reads that did not map to Sus scrofa
sequences on mirBase were aligned to the ASFV BA71V genome (GenBank accession no. U18466.2) and
ASFV Benin 97/1 genome (GenBank accession no. AM712239.1). Sequencing data were deposited in NCBI
GEO database under accession no. GSE115512.
Differential expression analysis. Initial raw counts were filtered to include only those with an
average of 5 reads or more. The counts within each sample were converted to abundances, which were
(i) multiplied by one million to generate a read set and (ii) one count added to all to preclude zero counts
instances, and (iii) the resultant values were converted to log2 and quantile normalized. Pairwise
comparisons of sample groups were performed on the normalized tag counts using linear modeling
(Bioconductor limma package). A series of 6 group-wise comparisons using empirical Bayesian ap-
proaches was undertaken to identify differences (fold changes). Significance values are controlled for
false discovery, yielding a more rigorous adjusted P value.
RT-qPCR. For small RNA analysis, cDNA was generated using the miScript II RT kit (Qiagen), and for
mRNA analysis, cDNA was generated using the oligo(dT)20-primed SuperScript III first-strand synthesis
system for RT-PCR (Invitrogen). qPCR was performed using the miScript SYBR green PCR kit (Qiagen)
using miScript primer assays for miRNAs and using the QuantiTect SYBR green PCR kit (Qiagen) for mRNA
in a Stratagene Mx3005P qPCR machine (Agilent). All qPCRs were performed in duplicate. Hs_RNU6-2_11
miScript Primer was used as a reference gene for sncRNA data normalization, and 18S rRNA was used for
mRNA data normalization. The PCR efficiency of each primer was determined by standard curve, and the
log2 fold change was calculated by the Pfaffl method.
Immunoprecipitation and Western blotting. Lysates were prepared by washing cells 2 in ice-cold
PBS before addition of an appropriate volume of radioimmunoprecipitation assay lysis buffer (Thermo-
Fisher) supplemented with protease inhibitor (Complete protease inhibitor cocktail tablets; Roche) and,
for immunoprecipitation, RNase inhibitor (ThermoFisher). Protein concentrations were determined using
the bicinchoninic acid protein assay kit (Thermo Scientific Pierce). For immunoprecipitation, equal
amounts of protein were incubated with either a rabbit polyclonal anti-Ago2 antibody or preimmune
rabbit sera overnight at 4°C. This was followed by a 1-h incubation at room temperature with 25 l Pierce
protein A magnetic beads (Thermo Scientific). The beads were washed and resuspended and then either
prepared for Western blotting or added to QIAzol lysis reagent for RNA extraction. For Western blotting,
lysates or bead suspensions were prepared by mixing 20 g of protein with 2 protein sample loading
buffer (Li-Cor) and heated to 98°C for 5 min. Samples were loaded onto a 15% polyacrylamide resolving
gel layered with a 5% stacking gel, alongside a prestained protein ladder (Bio-Rad), and the proteins
separated by electrophoresis. Proteins were transferred to a polyvinylidene difluoride membrane using
a wet transfer technique. Membranes were first blocked for 1 h at room temperature in a 1:1 mixture of
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PBS and Odyssey blocking buffer (Li-Cor) and then incubated with the primary antibodies diluted in
Odyssey blocking buffer and 0.1% Tween at 4°C overnight. Membranes were washed 4 for 5 min in PBS
containing 0.1% Tween before being incubated with the secondary antibodies diluted in Odyssey
blocking buffer and 0.1% Tween for 45 min at room temperature. Primary antibodies used were rabbit
anti-Ago2 (kindly provided by F. Gray), rat anti-HA, rabbit anti-actin (Cell signaling), and mouse anti-actin
(Cell Signaling). The secondary antibodies were DyLight 680 and 800 (Cell Signaling). Membranes
underwent a further 4 5-min washes in PBS-Tween and were then visualized on a G:Box (Syngene).
Plasmid and RNA mimic transfection. Vero cells were seeded at an appropriate density 24 h before
transfection. Both plasmid DNA and RNA mimics were transfected using Transit-X2 (Mirus) by following
manufacturer’s protocol. In brief, 500 ng DNA and/or 10 M RNA mimic was diluted in 50 l Opti-MEM
(LifeTech), and 1.5 l transfection reagent was added and incubated for 15 min at room temperature
before adding to 1 well of a 24-well plate. The single-stranded RNA mimics were synthesized (Sigma) with
5=-phosphorylation and 2’-fluoro modification for stability. The sequences of the RNA mimics were the
following: ASFVsRNA2 mimic, AUCAAUAGGACUGCUAUA; ASFVsRNA2 poly(U) mimic, AUCAAUAGGACU
GCUAUAUUUUUUU; negative control, UUCUCCGAACGUGUCACGU. The miRIDIAN microRNA mimic trans-
fection control with Dy547 was sourced from Dharmacon. Mimics were transfected to give a final
concentration of 25 nM per well.
One-step growth curve. Vero cells were transfected with RNA mimics as described above and
incubated for 14 h at 37°C. Cells were then infected with ASFV Ba71v at an MOI of 5 for 1 h at 37°C and
washed 3, and then medium was replaced. Virus was harvested at 0, 4, 8, 12, and 24 hpi by scraping
the cells into the medium and freeze-thawing 3. Viral titers were determined by immunofluorescence
TCID50 assay on Vero cells using an antibody against ASFV P30 protein. TCID50 was calculated using the
Spearman-Karber method.
Immunofluorescence. Cells were fixed after 3 washes in ice-cold PBS with 10% formalin and
incubated for 30 min at room temperature. Cells were washed again 3 in PBS, permeabilized by the
addition of 0.2% Triton X-100 diluted in PBS for 5 min at room temperature and washed a further 3 in
PBS. The primary antibody (mouse anti-ASFV P30) was diluted in PBS with 2% FBS and incubated with
the cells in a humidity chamber for 1 h. Cells were then washed 3 in PBS with 2% FBS and incubated
with secondary antibody (Alexa Fluor 488-conjugated goat anti-mouse IgG), and fluorescently tagged
phalloidin (Molecular Probes), in a humidity chamber for 1 h. Coverslips were stained with 300 nM
4=,6-diamidino-2-phenylindole (DAPI) (Life Technologies) for 5 min and then rinsed 3 in PBS, with a final
rinse in distilled H2O before being mounted onto a microscope slide using Vectashield (Vector Labs).
Data availability. Raw data are available from the NCBI GEO database under accession no.
GSE115512.
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